Article Information
vol. 7 no. 297 297ra113
- Received for publication September 12, 2014
- Accepted for publication June 26, 2015
- .
Author Information
- Laszlo Prokai1,2,*,
- Vien Nguyen1,
- Szabolcs Szarka1,†,
- Puja Garg1,3,‡,
- Gauri Sabnis4,
- Heather A. Bimonte-Nelson5,6,
- Katie J. McLaughlin5,§,
- Joshua S. Talboom5,6,
- Cheryl D. Conrad5,
- Paul J. Shughrue7,¶,
- Todd D. Gould4,8,9,
- Angela Brodie4,
- Istvan Merchenthaler9,10,
- Peter Koulen3 and
- Katalin Prokai-Tatrai1,2
- 1Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
- 2AgyPharma LLC, Mansfield, TX 76063, USA.
- 3Vision Research Center and Departments of Ophthalmology and Basic Medical Science, University of Missouri–Kansas City, School of Medicine, Kansas City, MO 64108, USA.
- 4Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- 5Department of Psychology, Arizona State University, Tempe, AZ 85287, USA.
- 6Arizona Alzheimer’s Consortium, Tempe, AZ 85014, USA.
- 7Department of Pharmacology, Elan Pharmaceuticals Inc., South San Francisco, CA 94080, USA.
- 8Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- 9Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- 10Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- ↵*Corresponding author. E-mail: laszlo.prokai{at}unthsc.edu